Navigation Links
Product Shifts are Occurring in the Renal Anemia and Bone and Mineral Metabolism Markets According to the Most Recent TreatmentTrends(R): US Nephrology Report from BioTrends Research Group
Date:4/27/2009

EXTON, Pa., April 27 /PRNewswire/ -- BioTrends Research Group, Inc. released TreatmentTrends(R): US Nephrology, a syndicated report based on online survey results from over 200 US Nephrologists.

In the ESA market, changes that have occurred seem to have taken place at the product level, while the overall use of ESAs has remained stable compared to the same period last year. Among patients with Chronic Kidney Disease not on dialysis (CKD), market share for Ortho Biotech's Procrit has been trending upward compared to the first quarter of 2008, primarily at the expense of Amgen's Aranesp. And while only about one-third of Nephrologists report that managed care policies have led to a decreased use of ESAs, Aranesp seems to be more negatively impacted by managed care than Procrit.

There have been no significant changes in the use of IV iron in the past year although Nephrologists project significant increases in the use of IV iron among CKD patients in the next three months. American Regent's Venofer continues to hold the position as market leader among CKD patients. In the hemodialysis market, use of Watson's Ferrlecit decreased while Fresenius Medical Care's Venofer, the market leader, experienced share growth year over year. The greatest share growth came from Nephrologists primarily affiliated with FMC. Nephrologists continue to await the approval of AMAG's Feraheme and familiarity with the product is on the rise.

Product shifts have also been the theme in the phosphate binder market where use of Genzyme's Renvela continues to take hold primarily at the expense of Genzyme's Renagel, although the move away from calcium-based binders in both dialysis and CKD continues. Close to 90% of Nephrologists report having at least some hemodialysis patients on Renvela compared to 67% in the previous quarter. Sevelamer is the market leader in dialysis with 55% share. Among CKD patients, sevelamer and FMC's PhosL
'/>"/>

SOURCE BioTrends Research Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Physician Skin Care Specialist Says Proposed New Rules for Sunscreen Products Will Better Protect the Public
3. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
4. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
5. End-to-End HR Performance Benchmarks: Metrics That Will Help Turn the HR Cost Center into a Productivity Driver
6. Boston Micromachines Multi-DM Named One of the Years Most Innovative Products
7. Drug Detection Kits Manufactured By IDenta Corp. Shown During French Television Broadcast (at TF1) - Product Aids French Police In Bust of 600 Kilograms Of Cocaine
8. Why Are Most Health & Wellness Products Doomed to Failure?
9. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
10. GladRags Introduces the Moon Cup - An Environmentally-Sound and Safe Alternative to Disposable Feminine Hygiene Products!
11. OneBeacon Professional Partners to Offer Podiatrist Medical Malpractice Product

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... Caregiving: Ready or Not helps families prepare f... Cincinnati, Ohio (PRWEB) December 2,...ssion to help families understand and embrace the ... hope our loved ones live long, healthy and prospe...e care at some point, and their needs often become...
(Date:12/1/2009)... Free hearing aids will be given by Estes Audiolog... Austin, TX (PRWEB) December 1, 2...a professional hearing healthcare provider dedicat...and their families, announced today the beginning ...way. Each year, Estes Audiology donates two pairs...
(Date:12/1/2009)... Anthony M. Marlon, MD was elected to the Stemedic...) Board of Directors at the Company’s Novemb...(PRWEB) December 1, 2009 -- Anthony M. Marlon, MD ...Inc. (“Stemedica”) Board of Directors .... Roger J. Howe, PhD, Executive Chairman for Steme...
(Date:12/1/2009)...CH, Calif., Dec. 1 To date, hospit...ll reimburse them for the $20 cost of the disposab... for surgery. ,, Anesthesiologists have not tol...void postop dementia from routine anesthesia over-... the ,avoid over-medication, message from their le...
(Date:12/1/2009)... Dec. 1 Cell Therapeut...s presentation at the 21st Annual Piper Jaffray He...00 a.m. Eastern Time will be webcast live at www....ll take place in Holmes 1 at the New York Palace H...the presentation. , , Piper ...
Breaking Medicine News(10 mins):Health News:Aging Expert's New Book Helps Boomers Address Challenges of Caregiving 2Health News:Estes Audiology Offers the Gift of Hearing to Celebrate the Holiday Season 2Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 2Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 3Health News:5 Shocking Reasons Your Brain Isn't Worth Twenty Bucks Exposed 2
...ish Medical Journal has suggested that pharmaceuti... sexual disorders and are defining the condition i... Drug companies are trying to recreate// the ki...ers are being unduly medicalised and the coining o...
... cancer cannot be prolonged by psychological inter... Does mind play a role in cancer? Yes. People wit.../ at the time of diagnosis to help them cope with ...ranteed for sure. A team at Peninsula Medical...
...teenagers heading back to school is the attack of ...ern Medical Center say that stress is one of the m...ress produces increased secretion of the hormone a... are already underway. Pimples occur when excess o...
...n found by researchers to be more effective than p...h borderline personality disorder. This study , wh...en with borderline// personality disorder between ...impulsivity and aggression when given fluvoxamine ...
...researchers have observed that there is evidence w...the best way forward in peripheral arterial diseas... will be affected by peripheral arterial disease (...ould think walking would be the worst thing you co...
...otein in the eye has prevented and stopped autoimm...s say this could lead to promising treatments for ...osis and type 1 diabetes. Scientists from the...nset of and stop the progression of uveitis in mic...
Other Medicine News:
(Date:11/30/2009)...VINA, Calif., Nov. 30 StemCyte, In...ation agreement with Academia Sinica, the National...hods and Intellectual Property (IP) related to the...s method and IP was pioneered by a team led by Pro...inica. Professor Lin is currently the exclusive c...
(Date:11/30/2009)..., NEW YORK, Nov. 30 Reportlinker.c...available in its catalogue: ,, Inflammatory Di...mune Response ,, http://www.reportlinker.com/...press-or-Balance-the-Immune-Response.html ,, T...ng an individual body or producing an exaggerated ...
(Date:11/30/2009)...ALTON, Ill., Nov. 30 The Simmons l...dedicated to representing thousands of women that ...the popular birth control pill manufactured and ma...dicial Panel on Multidistrict Litigation has order...ill lawsuits be consolidated and centralized for p...
Breaking Medicine Technology:StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 2Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 3Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 4Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 5Simmons Firm's Partner Trent Miracle Chosen to Help Lead National Litigation Against Bayer 2Drugs for Inflammatory Bowel Might Increase Cancer Risk 59751 1Drugs for Inflammatory Bowel Might Increase Cancer Risk 59751 2Majesco Entertainment and Interactive Game Group Release Jillian Michaels Fitness Ultimatum 2010 For Nintendo DS 28TM 29 59747 1Majesco Entertainment and Interactive Game Group Release Jillian Michaels Fitness Ultimatum 2010 For Nintendo DS 28TM 29 59747 2Majesco Entertainment and Interactive Game Group Release Jillian Michaels Fitness Ultimatum 2010 For Nintendo DS 28TM 29 59747 3IPRO Wins Federal Contract to Support Hospice Oversight 59743 1IPRO Wins Federal Contract to Support Hospice Oversight 59743 2
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
Medicine Products: